Author:
OGAWA KAZUEI,IKEDA KAZUHIKO,FURUKAWA MIKI,HARADA-SHIRADO KAYO,MASHIMO YUMIKO,TAKAHASHI HIROSHI,MATSUMOTO HAYATO,KIMURA SATOSHI,SHICHISHIMA-NAKAMURA AKIKO,OHKAWARA HIROSHI,HASHIMOTO YUKO,ASAHI KOICHI,NOJI HIDEYOSHI,OHTO HITOSHI,TAKEISHI YASUCHIKA
Publisher
The Fukushima Society of Medical Science
Reference23 articles.
1. 1. Kyle RA, Gertz MA. Primary systemic amyloidosis: clinical and laboratory features in 474 cases. Semin Hematol, 32: 45-59, 1995.
2. 2. Dubrey SW, Cha K, Anderson J, Chamarthi B, Reisinger J, Skinner M, Falk RH. The clinical features of immunoglobulin light-chain (AL) amyloidosis with heart involvement. QJM, 91: 141-157, 1998.
3. Renal involvement in systemic amyloidosis--an Italian retrospective study on epidemiological and clinical data at diagnosis
4. New advances in renal amyloidosis
5. 5. Dember LM, Sanchorawala V, Seldin DC, Wright DG, LaValley M, Berk JL, Falk RH, Skinner M. Effect of dose-intensive intravenous melphalan and autologous blood stem-cell transplantation on AL amyloidosis-associated renal disease. Ann Intern Med, 134: 746-753, 2001.